Picture of Pegasus Mercantile logo

LOAN Pegasus Mercantile Share Price

0.000.00%
ca flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+63.57%
3m-6.63%
6m-63.23%
1yr-58.69%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-60%
50d MA-29.43%
200d MA-46.75%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Sep 202530th Sep 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Pegasus Mercantile EPS forecast chart

Profile Summary

Pegasus Mercantile Inc. is a Canada-based prospect generator that provides companies with technology, financial, operational, and management assistance in the market for global wellness products and novel consumer goods and services. The Company is focused on hemp, cannabidiol (CBD), related, functional mushrooms, psilocybin plus other psychedelics, helping companies create sustainable products that elevate their personal health and wellbeing. It is focused on the specific areas of pain, depression and mental illness. By investing in pioneering techniques, such as micro-dosing using organic compounds and synthetic molecules. It is transforming the treatment of chronic pain, psychiatric ailments and depression by pioneering trials of fixed-dose drugs, combining psilocybin, ketamine, and MDMA, embracing the endless possibilities of micro-dosing. It has 100% interest in Shanti Therapeutics Pty Ltd. (Shanti), which is focused on psychedelic MDMA-based drug development research.

Directors

    Last Annual
    September 30th, 2024
    Last Interim
    March 31st, 2025
    Incorporated
    January 30th, 2006
    Public Since
    June 21st, 2006
    Sector
    Investment Banking & Investment Services
    Industry
    Financials
    Exchange
    ca flag iconCanadian Securities Exchange
    Shares in Issue
    13,369,567

    LOAN Share Price Performance

    Upcoming Events for LOAN

    Similar to LOAN

    Picture of AAPKI Ventures logo

    AAPKI Ventures

    ca flag iconCanadian Securities Exchange

    Picture of Axcap Ventures logo

    Axcap Ventures

    ca flag iconCanadian Securities Exchange

    Picture of Belgravia Hartford Capital logo

    Belgravia Hartford Capital

    ca flag iconCanadian Securities Exchange

    Picture of Birchtree Investments logo

    Birchtree Investments

    ca flag iconCanadian Securities Exchange

    Picture of Blackhawk Growth logo

    Blackhawk Growth

    ca flag iconCanadian Securities Exchange

    FAQ